Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists
-
Add time:09/10/2019 Source:sciencedirect.com
A series of substituted 4-arylpiperidines and a smaller family of 4-aryl-1,2,3,6-tetrahydropyridines were synthesized and their biological activity at the 5-HT2C receptor studied to determine whether either series showed noteworthy agonist activity. Structure–activity relationships were developed from the performed receptor binding assays and functional studies, and the results of the analysis are presented herein.
We also recommend Trading Suppliers and Manufacturers of 1,2,3,6-TETRAHYDROPYRIDINE HYDROCHLORIDE (cas 18513-79-6). Pls Click Website Link as below: cas 18513-79-6 suppliers
Prev:4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors
Next:Chapter 91 - The Neuropathology of Movement Disorders in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) and Methcathinone (Ephedrone) Addictions) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-TETRAHYDROPYRIDINE HYDROCHLORIDE (cas 18513-79-6) treated marmoset with the melatonin analogue ML-2309/27/2019
- Research ArticleMulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model09/26/2019
- Synthesis of new 4-[2-(4-methyl(amino)sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1,2,3,6-tetrahydropyridines: A search for novel nitric oxide donor anti-inflammatory agents09/25/2019
- Chapter 91 - The Neuropathology of Movement Disorders in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) and Methcathinone (Ephedrone) Addictions09/24/2019
- 4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors09/09/2019
- Expedient synthesis of 3-substituted-1,2,3,6-tetrahydropyridines09/08/2019
- Research reportDecreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice09/07/2019
- 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice09/06/2019
- Original articleEXPERIMENTAL STUDY OF ANTIPARKINSONIAN ACTION OF THE HARMINE HYDROCHLORIDE ORIGINAL COMPOUND09/05/2019
